Replimune Group (REPL) Reiterated at Overweight by Cantor Fitzgerald Aug 12, 2026 07:37AM
Replimune prices $150M stock offering at $12.06 per share Aug 10, 2026 08:01AM
Replimune Announces Pricing of $150 Million Underwritten Offering Aug 10, 2026 08:00AM
Cantor Fitzgerald Upgrades Replimune Group (REPL) to Overweight Jul 31, 2026 03:54AM
Cantor Fitzgerald Downgrades Replimune Group (REPL) to Neutral Apr 10, 2026 04:16PM


Nov 12, 2025 07:43AM Replimune's (REPL) RP1s Likely to Get Accelerated Approval - Cantor Fitzgerald
Jul 30, 2025 01:43PM Cantor Fitzgerald Upgrades Replimune Group (REPL) to Overweight
Jul 22, 2025 09:09AM Cantor Fitzgerald Downgrades Replimune Group (REPL) to Neutral, Only Firm Thus Far Not Buy/Overweight Rated
Jun 25, 2025 07:04AM Cantor Fitzgerald Reiterates Overweight Rating on Replimune Group (REPL)
Jun 20, 2025 06:09AM Cantor Fitzgerald Starts Replimune Group (REPL) at Overweight
Oct 21, 2020 09:27AM Pre-Open Stock Movers 10/21: (ASTC) (SNAP) (CALX) Higher; (GSX) (NAVI) (NFLX) Lower (more...)
Oct 20, 2020 05:33PM After-Hours Stock Movers 10/20: (ASTC) (SNAP) (PRTA) Higher; (NAVI) (NFLX) (APTX) Lower (more...)